Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7899023 | 0.96 | ADORA1 (0.57) | ADORA1SLC6A3 | |
| SCHEMBL15308422 | 0.93 | ADORA1 (0.57) | ADORA1SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL3730640 | 0.92 | ADORA1 (0.53) | ADORA1SLC6A3 | |
| SCHEMBL7899853 | 0.92 | ADORA1 (0.61) | ADORA1SLC6A3 | |
| SCHEMBL7900443 | 0.92 | ADORA1 (0.52) | ADORA1SLC6A3 | |
| SCHEMBL7905951 | 0.92 | ADORA1 (0.56) | ADORA1SLC6A3 | |
| SCHEMBL7899772 | 0.91 | ADORA1 (0.52) | ADORA1SLC6A3 | |
| SCHEMBL3732614 | 0.90 | ADORA1 (0.54) | ADORA1SLC6A3 | |
| SCHEMBL13227892 | 0.89 | ADORA1 (0.52) | ADORA1SLC6A3 | |
| SCHEMBL7894353 | 0.89 | ADORA1 (0.59) | ADORA1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140296515-A1 | ALKYLAMINE-SUBSTITUTED DICYANOPYRIDINE AND AMINO ACID ESTER PRODRUGS THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2014-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296515-A1 | ALKYLAMINE-SUBSTITUTED DICYANOPYRIDINE AND AMINO ACID ESTER PRODRUGS THEREOF | AADAT, DDC, DNPEP | ADORA1 402/4885SLC6A3 399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.